You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fibroblast Growth Factor 23 (FGF23)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibroblast Growth Factor 23, Anemia, CKD Trial in Córdoba

Active, not recruiting
  • Fibroblast Growth Factor 23
  • +2 more
    • Córdoba, Spain
      Hospital Universitario Reina Sofia
    Apr 27, 2022

    Healthy, Chronic Kidney Disease Trial in Birmingham (Diet)

    Completed
    • Healthy
    • Chronic Kidney Disease
    • Diet
    • Birmingham, Alabama
      University of Alabama
    Mar 10, 2021

    Selected Factors on Cardiovascular System in Chronic Kidney

    Completed
    • Atherosclerosis of Artery
    • +4 more
    • laboratory parameters - complete blood count
    • +23 more
    • Poznań, Poland
      Poznan University of Medical Sciences
    Jan 25, 2022

    Fibroblast Growth Factor 23 and Sclerostin in Relation to

    Not yet recruiting
    • COVID-19
    • Calcium
    • +3 more
    • Aswan, Egypt
      Aswan University hospital
    Mar 11, 2022

    Fibrous Dysplasia Of Bone Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (Burosumab)

    Not yet recruiting
    • Fibrous Dysplasia Of Bone
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    FGF23 as a Marker of Acute Kidney Injury

    Recruiting
    • Acute Kidney Injury
    • Kidney Ischemia
    • Plasmatic Fibroblast Growth Factor-23 by means of ELISA
    • Santiago, Chile
      Hospital Clinic Universidad de Chile
    Dec 30, 2020

    Fibroblast Growth Factor 23 in Chronic Respiratory Failure

    Not yet recruiting
    • Chronic Respiratory Failure
    • Dosage
    • Cardiac echography
    • (no location specified)
    Feb 17, 2022

    Fibroblast Growth Factor 23 and Hypertensive Disorder

    Recruiting
    • Hypertension, Pregnancy-Induced
      • Guangzhou, Guangdong, China
        Obstetrics and Gynechology Department of the 1st affiliated hosp
      Sep 5, 2021

      Fibroblast Growth Factor 21, Tast Perference Trial (Fibroblast growth factor 21 infusion, Placebo infusion (saline))

      Active, not recruiting
      • Fibroblast Growth Factor 21
      • Tast Perference
      • Fibroblast growth factor 21 infusion
      • Placebo infusion (saline)
      • Hellerup, Denmark
        Amalie R Lanng
      Nov 21, 2022

      NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)

      Completed
      • NAFLD
      • Soy isoflavone
      • Placebo
      • Ahvaz, Khuzestan, Iran, Islamic Republic of
        Asal Neshatbini Tehrani
      Oct 24, 2023

      Healthy Trial in Frederiksberg (Sucrose, Sucrose + protein, Sucrose + fat)

      Completed
      • Healthy
      • Sucrose
      • +2 more
      • Frederiksberg, Denmark
        Department of Nutrition, Exercise and Sports, University of Cope
      Mar 30, 2022

      Gestational Diabetes Trial in ChiangMai (blood draw)

      Active, not recruiting
      • Gestational Diabetes
      • blood draw
      • ChiangMai, Thailand
        Maharaj Nakorn ChiangMai Hospital
      Dec 1, 2022

      Fasting Trial in Boston (oral carbohydrate challenge)

      Active, not recruiting
      • Fasting
      • oral carbohydrate challenge
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Jul 18, 2022

      Markers of Metabolism and Vascular Access in ESRD

      Not yet recruiting
      • Disorders of Calcium and Bone Metabolism
      • vascular acess
      • (no location specified)
      May 2, 2023

      Chronic Kidney Disease Trial in Montpellier, Saint-Jean-de-Védas (Plasma osteoprotegerin level, Plasma fibroblast growth factor

      Recruiting
      • Chronic Kidney Disease
      • Plasma osteoprotegerin level
      • +2 more
      • Montpellier, France
      • +6 more
      Dec 31, 2021

      Tympanic Membrane Perforation Trial in Boston, Lackland Air Force Base (FGF-2, Placebo)

      Completed
      Has Results
      • Tympanic Membrane Perforation
      • Boston, Massachusetts
      • +1 more
      Dec 7, 2020

      Chronic Kidney Disease Trial in France (Plasma osteoprotegerin level, Plasma fibroblast growth factor 23 level, Vascular

      Recruiting
      • Chronic Kidney Disease
      • Plasma osteoprotegerin level
      • +2 more
      • Castelnau Le Lez, France
      • +4 more
      Apr 13, 2022

      Acute Kidney Injury, Uremic; Toxemia, Vascular Dysfunction Trial in Amiens (blood sample)

      Recruiting
      • Acute Kidney Injury
      • +4 more
      • blood sample
      • Amiens, France
        Amiens hospital
      Dec 13, 2022

      Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS), Epidermal Nevus Syndrome Trial in Washington (Burosumab)

      Active, not recruiting
      • Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
      • Epidermal Nevus Syndrome
      • Washington, District of Columbia
        Children's National Hospital
      Mar 4, 2022

      Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Co-Enzyme Q10
      • (no location specified)
      Jul 4, 2023

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      X-linked Hypophosphatemia Trial in Worldwide (burosumab)

      Completed
      Has Results
      • X-linked Hypophosphatemia
      • burosumab
      • San Francisco, California
      • +8 more
      Jul 8, 2019

      Bone in Pediatric Gaucher Disease Related to Bone Pathology in

      Recruiting
      • Gaucher Disease
      • Bone Diseases
        • Fairfax, Virginia
          Lysosomal and Rare disorder research and treatment center
        Nov 6, 2023

        Inappropriate Secretion of FGF23 in Patients Followed in

        Recruiting
        • Hypophosphatemia Without Immediate Anteriority
        • Unexplained Hypophosphatemia
        • unexplained hypophoshatemia
        • Clermont-Ferrand, France
        • +1 more
        Mar 10, 2022

        Healthy Volunteers Trial run by the NIDDK (Placebo, Canagliflozin)

        Completed
        • Healthy Volunteers
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023